Turner Heather D
Former EVP, GC & Sec. at ATRA; SVP, Gen. Counsel & Secretary at Orexigen Therapeutics, Inc.
- Sold, on record
- $2.9M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Feb 9, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ATRAAtara Biotherapeutics, Inc.Former EVP, GC & Sec.
- Orexigen Therapeutics, Inc.SVP, Gen. Counsel & Secretary
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Orexigen Therapeutics, Inc.436,464 shares
- ATRA24,429 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Orexigen Therapeutics, Inc.UnusualJul 17 2012
Sold 82,433 shares at $7.68 ($633k)
Turner Heather D, SVP, Gen. Counsel & Secretary
Sold 100% of holdings ($633k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Orexigen Therapeutics, Inc.UnusualSep 22 +797 days
Sold 300,000 shares at $4.47 ($1.3M)
Turner Heather D, VP, Gen. Counsel & Secretary
Sold 100% of holdings ($1.3M position)0 shares leftFirst sale on recordFiling
- 3 Form 4 sale Orexigen Therapeutics, Inc.UnusualNov 25 +64 days
Sold 31,388 shares at $5.82 ($183k)
Turner Heather D, SVP, Gen. Counsel & Secretary
Sold 100% of holdings ($183k position)0 shares leftFiling
- 4 Form 4 sale Orexigen Therapeutics, Inc.UnusualDec 2 +7 days
Sold 22,643 shares at $6.00 ($136k)
Turner Heather D, SVP, Gen. Counsel & Secretary
Sold 100% of holdings ($136k position)0 shares leftFiling
- 5 Form 4 sale ATRAPlan not statedFeb 9 +800 days
Sold 12,215 shares at $15.72 ($192k)
Turner Heather D, EVP, General Counsel & Sec.
Sold 12.4% of holdings ($1.5M position)86,142 shares leftFirst sale on recordFiling
- 6 Form 4 sale ATRAPlan not statedFeb 9 +365 days
Sold 12,214 shares at $38.01 ($464k)
Turner Heather D, Former EVP, GC & Sec.
Sold 14.9% of holdings ($3.1M position)69,494 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2018 | ATRA | Former EVP, GC & Sec. | Form 4 sale | 12,214 | $464k | 14.9% | Plan not stated | SEC |
| Feb 9, 2017 | ATRA | EVP, General Counsel & Sec. | Form 4 sale | 12,215 | $192k | 12.4% | Plan not stated | SEC |
| Dec 2, 2014 | Orexigen Therapeutics, Inc. | SVP, Gen. Counsel & Secretary | Form 4 sale | 22,643 | $136k | 100.0% | Unusual | SEC |
| Nov 25, 2014 | Orexigen Therapeutics, Inc. | SVP, Gen. Counsel & Secretary | Form 4 sale | 31,388 | $183k | 100.0% | Unusual | SEC |
| Sep 22, 2014 | Orexigen Therapeutics, Inc. | VP, Gen. Counsel & Secretary | Form 4 sale | 300,000 | $1.3M | 100.0% | Unusual | SEC |
| Jul 17, 2012 | Orexigen Therapeutics, Inc. | SVP, Gen. Counsel & Secretary | Form 4 sale | 82,433 | $633k | 100.0% | Unusual | SEC |